Vertex Pharmaceuticals, Inc.

Faith Witkos

Tiansheng Wang

Michael Aaron Brodney

Jingrong Cao

Brian Ledford

Jon H Come

Ales Medek

Yi Shi

Suganthini S Nanthakumar

Kevin Gagnon

Warren A Dorsch

Peter Jamison Rose

Elaine B Krueger

Muna Shrestha

Timothy J Senter

Leslie A Dakin

Olivier Nicolas

Camil Sayegh

Anne Fortier

Francois Denis

Kan-Nian Hu

Martine Hamel

The disclosure provides at least one entity chosen from compounds of formula (I), solid state forms of the same, compositions comprising the same, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD).

Inhibitors of APOL1 and methods of using same

The disclosure provides a compound of Formula (I), including deuterated derivatives, pharmaceutically acceptable salts, and solvates thereof, solid state forms of those compounds, compositions comprising those compounds and solid forms, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD). 

Growing community of inventors

Attleboro, MA, United States of America

Faith Witkos